Position in BCAB
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$59,177
-$139,483 QoQ
Shares Held
14,294
-98.8% QoQ
Ownership
0.858%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#5
of 21 holders
Holding Since
Jun 2022
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BCAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ACADIAN ASSET MANAGEMENT LLC holds $730,930,536 across 167 Biotechnology names. BCAB ranks #148 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
1,664,999 | $188,744,286 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,440 | $98,170,137 | |
| 3 | IMCR |
Immunocore Holdings plc
|
1,209,894 | $38,414,134 | |
| 4 | RIGL |
Rigel Pharmaceuticals Inc
|
591,686 | $23,146,756 | |
| 5 | EXEL |
Exelixis, Inc.
|
421,444 | $22,930,768 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
42,122 | $20,923,261 | |
| 7 | TBPH |
Theravance Biopharma, Inc.
|
1,174,910 | $19,973,470 | |
| 8 | PRTA |
Prothena Corp Public Ltd Co
|
2,010,645 | $19,684,214 |
All Filings in BCAB
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $59,177 | 14,294 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $198,660 | 1,233,919 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $430,357 | 757,671 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $640,157 | 930,462 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $591,050 | 1,492,552 | Shares | Defined | 2025-08-07 | |
| 2025-03-31 | $586,468 | 1,690,110 | Shares | Defined | 2025-05-21 | |
| 2024-12-31 | $93,446 | 158,116 | Shares | Defined | 2025-02-11 | |
| 2024-06-30 | $102,792 | 75,031 | Shares | Defined | 2024-08-06 | |
| 2024-03-31 | $533,846 | 155,188 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $242,162 | 98,440 | Shares | Defined | 2024-02-13 | |
| 2023-03-31 | $248,390 | 92,683 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $446,349 | 54,103 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $765,949 | 99,474 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $434,616 | 152,497 | Shares | Defined | 2022-08-09 | |
| No filing history on record for this holder in this stock. | ||||||